Evidence map›Paper›PMID 42384641›Full record

ArticlePLoS biology2026

Towards globally equitable bioinformatics adoption.

Paulyna Magaña, Piraveen Gopalasingam, Jennifer R Fleming, Oleg Kovalevskiy, Augustin Žídek, ThankGod Echezona Ebenezer, Agata Laydon, Roz Onions, Eva Akurut, Syed Muktadir Al Sium and 28 more

Abstract read
In one paragraph

Article in PLoS biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Paulyna MagañaEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Piraveen GopalasingamEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Jennifer R FlemingEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Oleg KovalevskiyGoogle DeepMind, London, United Kingdom.
Augustin ŽídekGoogle DeepMind, London, United Kingdom.
ThankGod Echezona EbenezerEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Agata LaydonGoogle DeepMind, London, United Kingdom.
Roz OnionsGoogle DeepMind, London, United Kingdom.
Eva AkurutAfrican Center of Excellence in Bioinformatics and Data-Intensive Science, Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Syed Muktadir Al SiumBangladesh Council of Scientific and Industrial Research, Dhaka, Bangladesh.
Yalbi Itzel Balderas-MartínezInstituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico.
Sanjana Fatema ChowdhuryBangladesh Council of Scientific and Industrial Research, Dhaka, Bangladesh.
Saikat ChowdhuryCSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana, India.
Sylvia ChristieGoogle DeepMind, London, United Kingdom.
Govinda Rao DabburuUniversity of Delhi, South Campus, New Delhi, India.
Fatoumata Gnine FofanaAfrican Centre of Excellence in Bioinformatics and Data Sciences (ACE-Mali), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Ronald GaliwangoAfrican Center of Excellence in Bioinformatics and Data-Intensive Science, Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Mahipal GanjiDepartment of Biochemistry, Indian Institute of Science, Bangalore, India.
Daudi JjingoAfrican Center of Excellence in Bioinformatics and Data-Intensive Science, Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Fredrick Elishama KakemboAfrican Center of Excellence in Bioinformatics and Data-Intensive Science, Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Grace KebirungiAfrican Center of Excellence in Bioinformatics and Data-Intensive Science, Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Shahiid KiyagaAfrican Center of Excellence in Bioinformatics and Data-Intensive Science, Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Ayoub KsouriSydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Sanjeet Kumar MahthaNational Institute of Immunology, New Delhi, India.
Vinicius Maracaja-CoutinhoUnidad de Genómica Avanzada (UGA), Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago, Chile.
Jack MasonGoogle DeepMind, London, United Kingdom.
Jose Arturo Molina-MoraCentro de Investigación en Enfermedades Tropicales, Centro de Investigación en Hematología y Trastornos Afines, and Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica.
Patricia P N NabisubiAfrican Center of Excellence in Bioinformatics and Data-Intensive Science, Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Emmanuel NjiBioStruct-Africa, Stockholm, Sweden.
Houcemeddine OthmanSydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Martina Soledad PaolettaInstituto de Agrobiotecnología y Biología Molecular (IABIMO), INTA-CONICET, Hurlingham, Argentina.
Nicole M SchererBioinformatics Core, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
Bhagya SenadheeraThe Allergy, Immunology and Cell Biology Unit, Faculty of Medical Sciences, Colombo, Sri Lanka.
Adrián Gustavo TurjanskiUniversidad de Buenos Aires, Buenos Aires, Argentina.
David TwesigomweSydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Andrew WalakiraAfrican Center of Excellence in Bioinformatics and Data-Intensive Science, Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Sameer VelankarEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.
Cath BrooksbankEMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0001-9395-7001

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in artificial intelligence (AI)-driven bioinformatics promise democratized discovery, yet major inequities persist. Equitable adoption of bioinformatics tools will require sustained investment in infrastructure, training, institutions, and global communities, not just access.

Indexed as

Artificial IntelligenceComputational BiologyHumans

Identifiers

PMID42384641
PMCPMC13325435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.